HotSpot Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, pioneering allosteric drug discovery by targeting "natural hotspots" — the regulatory on/off switches on proteins. Its Smart Allostery platform combines AI-driven mining of large, diverse structural and biological data sets with a tailored pharmacology toolkit and bespoke medicinal chemistry to design first-in-class oral small molecules, and has been applied across E3 ligases, kinases and transcription factors. The company has raised roughly $190M across Series A, B and C financings and advanced its lead candidate HST-1011, an oral allosteric CBL-B inhibitor, into first-in-human dosing for cancer, alongside programs in autoimmune disease. HotSpot sells medicines and research collaborations, not software: it publishes no public developer program, API, SDK or machine-readable contract of any kind.
HotSpot Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Life Sciences.
HotSpot Therapeutics’ developer surface includes engineering blog and 6 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: hotspot-therapeutics
name: HotSpot Therapeutics
description: 'HotSpot Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, pioneering
allosteric drug discovery by targeting "natural hotspots" — the regulatory on/off switches on proteins. Its Smart Allostery
platform combines AI-driven mining of large, diverse structural and biological data sets with a tailored pharmacology toolkit
and bespoke medicinal chemistry to design first-in-class oral small molecules, and has been applied across E3 ligases, kinases
and transcription factors. The company has raised roughly $190M across Series A, B and C financings and advanced its lead
candidate HST-1011, an oral allosteric CBL-B inhibitor, into first-in-human dosing for cancer, alongside programs in autoimmune
disease. HotSpot sells medicines and research collaborations, not software: it publishes no public developer program, API,
SDK or machine-readable contract of any kind.'
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: false
label: Hosted service · you call their endpoint
confidence: medium
source:
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://avatars.githubusercontent.com/u/105356575?v=4
url: https://raw.githubusercontent.com/api-evangelist/hotspot-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-22'
modified: '2026-08-22'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Life Sciences
- Oncology
- Immunology
- Artificial Intelligence
- Health
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/hotspot-therapeutics-domain-security.yml
- type: Website
url: https://www.hotspotthera.com/
- type: GitHubOrganization
url: https://github.com/HotSpot-Therapeutics
- type: Blog
url: https://www.hotspotthera.com/blog/
- type: PrivacyPolicy
url: https://www.hotspotthera.com/privacy-policy/
- type: TermsOfService
url: https://www.hotspotthera.com/terms-and-conditions/
- type: SecondaryMarketListing
url: https://forgeglobal.com/hotspot-therapeutics_stock/
x-enrichment:
date: '2026-08-22'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: HotSpot Therapeutics is a clinical-stage biopharmaceutical company whose product is an oral small-molecule drug
pipeline (HST-1011, a CBL-B allosteric inhibitor), not software — its "Smart Allostery" AI platform is an internal discovery
engine with no external interface, no api./docs./developer. host resolves in DNS, every /.well-known/ path 404s, and its
only public GitHub repo is a fork of the third-party SETH bioinformatics tool.
evidence:
- url: https://www.hotspotthera.com/.well-known/api-catalog
status: 404
- url: https://www.hotspotthera.com/llms.txt
status: 404
- url: https://hotspotthera.com/.well-known/agent-card.json
status: 404
- url: https://api.github.com/orgs/HotSpot-Therapeutics/repos
status: 200
checked: '2026-08-22'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.